A Pilot Study of Romidepsin for Therapy of Graft-versus-Host Disease
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
Price : $35 *
At a glance
- Drugs Romidepsin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Feb 2017 Status changed from active, no longer recruiting to discontinued.
- 08 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.